Corrigendum to "Evaluation of commercial quadrivalent foot-and-mouth disease vaccines against east African virus strains reveals limited immunogenicity and duration of protection" [Vaccine 42 (1-12) (2024) 126325]
Vaccine. 2025 Jan 1;43(Pt 1):126480.
doi: 10.1016/j.vaccine.2024.126480.
Epub 2024 Nov 5.